RCT Examining Effects of Probiotics in T2DM Individuals
A Double-blind, Randomized Placebo-controlled Parallel Group Study of Probiotics as an Adjuvant Therapy for Individuals With Type 2 Diabetes Mellitus
Sponsor: Universiti Kebangsaan Malaysia Medical Centre
Listed as NCT01752803, this NA trial focuses on Hyperlipidemia and Hypertension and remains ongoing. Sponsored by Universiti Kebangsaan Malaysia Medical Centre, it has been updated 5 times since 2012, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status NA
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status NA
First recorded
Dec 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Universiti Kebangsaan Malaysia Medical Centre
For direct contact, visit the study record on ClinicalTrials.gov .